Minimal residual disease status may help personalize myeloma treatment. The landscape of multiple myeloma is changing, which is now bringing in ways to help ...

Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.

The breakthrough therapy designation for inavolisib is based on findings from the phase 3 INAVO120 trial.The Food and Drug Administration (FDA) granted a ...

Certain days around cancer have remained in my brain, but none more so than the day my sister was diagnosed with Hodgkin lymphoma, July 9, 2014, and her ...

Strength training by using resistance bands or light dumbbells can help preserve physical decline in certain early-stage breast cancer survivors.Older ...

Kerewsky reminds herself that she too becomes the weeds in the soil.There Are Always WeedsThe weeds don’t end,can’t be extirpated,only held in ...

Guidance and support received As a new format for many, the narrative CV needs proper explanation. And while CRUK has made efforts to help (on top of ...

We’re back with the third episode of our subseries, Longer, better lives! This series unpacks our recently published manifesto, Longer, Better Lives: A ...

Aricept does not help improve cognitive impairment from chemotherapy, an expert told CURE®. Although Aricept (donepezil), a cognition-enhancing drug ...

Survival outcomes were not improved when patients received Onivyde versus chemotherapy in small cell lung cancer. For patients with relapsed small cell lung ...